Abstract 3387
Background
Patients undergoing haematopoietic stem cell transplantation (HSCT) are often hospitalised in protective isolation in order to reduce the risk of dangerous infection. However, they could experience isolation-related suffering, problems in relationships with others, and difficulties in relating to themselves. Oncology nurses might play an important role in mitigating perceived isolation and in providing emotional support. The aim of this study was to identify which factors can influence the level of emotional support from nurses perceived by patients with haematological malignancies undergoing HSCT in isolation.
Methods
A multicentre prospective study was conducted in 10 haematology centres of the Italian Group of stem cell transplant (GITMO). Emotional support from nurses was measured between day +7 and +9 post-transplant using the Scale Experiences on the Newcastle Satisfaction with Nurses Scale. Multiple linear regression analysis was performed.
Results
The participants were 186 adult patients receiving autologous (48%) or allogeneic (52%) HSCT in protective isolation. They were mainly male (61.6%) with a mean age of 50.1 (SD = 13.4; range=19-71). The regression model explained 23% of the total variance (p < .001) (Table). Sex, pain level, double room, satisfaction with information received before HSCT, and patients to nurse ratio were independently associated with emotional support from nurses.Table: CN56
Regression model predicting perceived emotional support from nurses (n = 186)
| β | 95% CI | P | |
|---|---|---|---|
| Sex (female) | .193 | (.056; .332) | .006 |
| Pain level | -.147 | (-.287; -.007) | .040 |
| First HSCT | .099 | (-.038; .234) | .158 |
| Double room | .242 | (.098; .378) | .001 |
| Satisfaction with info | .403 | (.264; .547) | <.001 |
| Patients to nurse | -.168 | (-.316; -.027) | .021 |
| P | <.001 |
Conclusions
Patients who reported high emotional support from nurses were female, with low pain, satisfied with information received, and hospitalised in double room in a ward with a low patients to nurse ratio. It is crucial to reduce the patients to nurse ratio in order to promote the role of nurses in providing emotional support.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Campus Bio-Medico di Roma University.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2452 - High proportion of multiple KRAS mutations in circulating tumor DNA and tumor tissue of pancreatic ductal adenocarcinoma
Presenter: Min Kyeong Kim
Session: Poster Display session 3
Resources:
Abstract
3328 - Biological difference of tumor mutational burden (TMB) and microsatellite instability (MSI) status in patients (pts) with somatic vs. germline BRCA1/2-mutated advanced gastrointestinal (GI) cancers using cell-free DNA (cfDNA) sequencing analysis in the GOZILA study
Presenter: Yasuyuki Kawamoto
Session: Poster Display session 3
Resources:
Abstract
3022 - Cell-Free DNA to Detect Focal Versus Non-Focal MET Amplification in Metastatic Colorectal Cancer Patients: Combined Analysis from Japan and the United States
Presenter: Mishima Saori
Session: Poster Display session 3
Resources:
Abstract
2833 - Presence of circulating tumor DNA in surgically resected renal cell carcinoma is associated with advanced disease and poor patient prognosis
Presenter: Andres Correa
Session: Poster Display session 3
Resources:
Abstract
1376 - Combined genomic and epigenomic assessment of cell-free circulating tumor DNA (cfDNA) for cancer diagnosis and recurrence-risk assessment in early-stage lung cancer
Presenter: Junghee Lee
Session: Poster Display session 3
Resources:
Abstract
4050 - DEMo: a prospective evaluation of a prognostic clinico-molecular composite score in NSCLC patients treated with immunotherapy.
Presenter: Arsela Prelaj
Session: Poster Display session 3
Resources:
Abstract
4727 - Bespoke circulating tumor DNA (ctDNA) analysis as a predictive biomarker in solid tumor patients (pts) treated with single agent pembrolizumab (P)
Presenter: Cindy Yang
Session: Poster Display session 3
Resources:
Abstract
3662 - Dynamic changes in whole-genome cell-free DNA (cfDNA) to identify disease progression prior to imaging in advanced solid tumors
Presenter: Andrew Davis
Session: Poster Display session 3
Resources:
Abstract
3817 - Evaluation of Microsatellite Instability Testing Through cell-free DNA sequencing
Presenter: Shile Zhang
Session: Poster Display session 3
Resources:
Abstract
3664 - Longitudinal changes in cell-free DNA (cfDNA) methylation levels identify early non-responders to treatment in advanced solid tumors
Presenter: Andrew Davis
Session: Poster Display session 3
Resources:
Abstract